Chronic lymphocytic leukemia (CLL) is a type of cancer affecting ... and Imbruvica (ibrutinib), and antiapoptotic protein B ...

Here, we review data concerning the configuration of the IG genes in CLL and how studies of these genes have shed light on the pathogenesis and progression of CLL. In normal B cells, replacement ...

Chronic lymphocytic leukemia (CLL) is a cancer that affects ... CLL can get worse and become a more aggressive cancer called diffuse large B-cell lymphoma, also called Richter's syndrome or ...

Chronic lymphocytic leukemia (CLL) is due to the unremitting accumulation of neoplastic CD5 + B cells in blood, bone marrow, and lymphoid tissues. The prognosis of patients with this form of leukemia ...

Chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL) are types of blood cancer. They develop in types of white blood cells called B cells or T cells, or the precursors to these cells.

Chronic lymphocytic leukemia (CLL) is a type of cancer that happens when a person’s bone marrow makes too many lymphocytes, one of the types of white blood cells that help your body fight infection.

a disease which cannot be fully understood when considered just as simple B-cell monoclonal malignancy. The Surveillance E, and End Results (SEER) Program of the National Cancer Institute, Cancer Stat ...

Zanubrutinib shows durable efficacy in CLL/SLL with 17p deletions, according to 5-year SEQUOIA trial data.

HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

Panelists discuss the primary access challenges in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) treatment, including financial barriers and health care system limitations, and how ...